These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30630471)

  • 1. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
    Otake K; Kamiguchi H; Hirozane Y
    BMC Med Genomics; 2019 Jan; 12(1):7. PubMed ID: 30630471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Hayashi N; Doi H; Kurata Y; Kagawa H; Atobe Y; Funakoshi K; Tada M; Katsumoto A; Tanaka K; Kunii M; Nakamura H; Takahashi K; Takeuchi H; Koyano S; Kimura Y; Hirano H; Tanaka F
    Neurosci Res; 2020 Nov; 160():43-49. PubMed ID: 31669371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.
    Yagi Y; Ohkubo T; Kawaji H; Machida A; Miyata H; Goda S; Roy S; Hayashizaki Y; Suzuki H; Yokota T
    Neurosci Lett; 2017 Jan; 636():48-57. PubMed ID: 27780738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal TAR DNA binding protein 43 profile in canine model of amyotrophic lateral sclerosis: a preliminary study in developing blood-based biomarker for neurodegenerative diseases.
    Pfeiffer P; Coates JR; Esqueda YM; Kennedy A; Getchell K; McLenon M; Kosa E; Agbas A
    Ann Med; 2023 Dec; 55(1):34-41. PubMed ID: 36495266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review.
    Darabi S; Ariaei A; Rustamzadeh A; Afshari D; Charkhat Gorgich EA; Darabi L
    Diagn Pathol; 2024 Mar; 19(1):47. PubMed ID: 38429818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
    Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Joilin G; Gray E; Thompson AG; Talbot K; Leigh PN; Newbury SF; Turner MR; Hafezparast M
    Ann Med; 2022 Dec; 54(1):3069-3078. PubMed ID: 36314539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease.
    Hou X; Gong X; Zhang L; Li T; Yuan H; Xie Y; Peng Y; Qiu R; Xia K; Tang B; Jiang H
    Epigenomics; 2019 Jul; 11(9):1037-1056. PubMed ID: 31144508
    [No Abstract]   [Full Text] [Related]  

  • 10. Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes.
    Rizzuti M; Melzi V; Gagliardi D; Resnati D; Meneri M; Dioni L; Masrori P; Hersmus N; Poesen K; Locatelli M; Biella F; Silipigni R; Bollati V; Bresolin N; Comi GP; Van Damme P; Nizzardo M; Corti S
    Cell Mol Life Sci; 2022 Mar; 79(3):189. PubMed ID: 35286466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis.
    Cheng P; Feng F; Yang H; Jin S; Lai C; Wang Y; Bi J
    J Mol Neurosci; 2021 Apr; 71(4):790-803. PubMed ID: 32959225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of exosome function in the CNS: implications for neurodegeneration.
    Properzi F; Ferroni E; Poleggi A; Vinci R
    Swiss Med Wkly; 2015; 145():w14204. PubMed ID: 26561744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis.
    Costa J; Streich L; Pinto S; Pronto-Laborinho A; Nimtz M; Conradt HS; de Carvalho M
    Mol Neurobiol; 2019 Aug; 56(8):5729-5739. PubMed ID: 30674035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.
    Barschke P; Oeckl P; Steinacker P; Ludolph A; Otto M
    Expert Rev Proteomics; 2017 Sep; 14(9):769-777. PubMed ID: 28799854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
    Nukui T; Matsui A; Niimi H; Sugimoto T; Hayashi T; Dougu N; Konishi H; Yamamoto M; Anada R; Matsuda N; Kitajima I; Nakatsuji Y
    BMC Neurol; 2021 Jun; 21(1):255. PubMed ID: 34193068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates.
    Sjoqvist S; Otake K
    Biochem Biophys Res Commun; 2022 Jul; 613():166-173. PubMed ID: 35567903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.